Ansem: Bitcoin needs to return above $112,000, otherwise a bull market cannot be seen
BlockBeats News, on October 19, crypto KOL Ansem posted that judging from the weekly charts of XRP, SOL, and ETH, he simply cannot be optimistic about this market, especially with BTC's price falling below its 2024 peak. He does not see a bull market scenario, but rather the end of momentum and a decline in prices.
The market lacks new narratives, MSTR also peaked in November 2024, and the ETH/BTC ratio has risen just as it does at the end of every cycle. The only thing that could change his mind is if bitcoin returns above $112,000.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
